PHILADELPHIA, June 17, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today the appointment of Robert Dickey IV as Senior Vice President. This is a newly created role at Hemispherx that will bring together various activities relating to fund raising, strategic partnering and finance functions. His role will also provide increased focus on strategic alliance evaluation and clinical project management, especially global clinical programs.
